Neonatal length and cranial circumference are reduced in human pregnancies at term after antepartum administration of betamethasone.
Piazze
Juan
J
Ruozi-Berretta
Angelo
A
Di Cioccio
Antonio
A
Anceschi
Maurizo
M
D001623:Betamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001827:Body Height; D005260:Female; D005325:Fetal Organ Maturity; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006257:Head; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D011295:Prenatal Care; D011446:Prospective Studies
D005938:Glucocorticoids; D001623:Betamethasone